XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
License and Collaboration Agreements (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 30, 2020
Jun. 30, 2022
Mar. 31, 2020
Jun. 30, 2022
Research and License Agreements        
Revenue from collaboration and license agreements   $ 75,000   $ 75,000
Apollomics, Inc.        
Research and License Agreements        
Up-front payment received     $ 9,000,000.0  
Milestones based on achievement of certain clinical and regulatory events     75,000,000.0  
Milestone payment upon achievement of specified net sales thresholds for all licensed products     $ 105,000,000.0  
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0      
Apollomics, Inc. | Maximum        
Research and License Agreements        
Tiered percentage of annual net sales     15.00%